To help spur economic development and assist in the battle against COVID-19, PNNL is making available its entire portfolio of patented technologies on a research trial basis—at no cost—through the end of 2020.
PNNL biomedical scientist Ernesto Nakayasu brings expertise in host-pathogen interactions and the interconnection between the immune response and cellular metabolism to provide constructive review for submitted manuscripts.
After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.
Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A long-standing collaboration between PNNL and Oregon State University to study harmful chemicals at federally designated hazardous waste sites primarily across the Pacific Northwest has been awarded a five-year, $12.7 million grant.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
The recent coronavirus pandemic shows just how quickly a deadly pathogen can sweep across the globe, killing tens of thousands in the U.S. and disrupting daily life for millions more in the span of a few months.
A PNNL scientist is studying the structures of the proteins on the surface of the novel coronavirus, using NMR spectroscopy to reveal information about the molecular toolkit that holds the keys to a vaccine or treatment.
Combining its strength in biological sciences and data analytics, researchers at the Department of Energy's PNNL are working to enable a quick response to a biological incident — whether intentional, accidental or natural.
David Manz, a PNNL cybersecurity scientist working to build more resilient architectures for the nation’s critical infrastructure, was inducted to the National Science Foundation’s CyberCorps: Scholarship for Service (SFS) Hall of Fame.
A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.
In a special edition of the Journal of Information Warfare, Pacific Northwest National Laboratory researchers explore the revolution of technologies defending the nation’s critical infrastructure.
PNNL and the 13 other national laboratories of the Grid Modernization Laboratory Consortium (GMLC) will be sharing their R&D work and technologies for grid modernization at DistribuTECH International in San Antonio Jan. 28-30.
While it’s one small step forward for mouse research, it’s a big step forward for understanding proteins, the molecular workhorses in biological organisms.
PNNL will lead three new grid modernization projects funded by the Department of Energy. The projects focus on scalability and usability, networked microgrids, and machine learning for a more resilient, flexible and secure power grid.
Seventeen teams from regional colleges and universities gathered at PNNL Nov. 16 to put their cyber skills to the test by protecting critical energy infrastructure against simulated cyberattacks as part of DOE's CyberForce Competition.
